|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-2-17
|
|
pubmed:abstractText |
Because of the low sensitivity of urinary cytological diagnosis of urinary bladder carcinoma, new molecular diagnostic methods have been proposed. We decided to verify the expression of telomerase mRNA coding for the catalytic component (hTRT), cytokeratin 20 (CK20) and CD4 antigen mRNAs in urine as possible diagnostic tool.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
327-33
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15716196-Antigens, CD4,
pubmed-meshheading:15716196-Humans,
pubmed-meshheading:15716196-Intermediate Filament Proteins,
pubmed-meshheading:15716196-Keratin-20,
pubmed-meshheading:15716196-Logistic Models,
pubmed-meshheading:15716196-Neoplasm Staging,
pubmed-meshheading:15716196-Prognosis,
pubmed-meshheading:15716196-Sensitivity and Specificity,
pubmed-meshheading:15716196-Telomerase,
pubmed-meshheading:15716196-Tumor Markers, Biological,
pubmed-meshheading:15716196-Urinary Bladder Neoplasms
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
|
|
pubmed:affiliation |
Department of Urology, Trieste University, Cattinara Hospital, Via Strada di Fiume 447, 34100 Trieste, Italy. siracus@univ.trieste.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
